BAY59-8862 (Cytotoxic Taxane)

DRUG2 trials

Sponsors

Bayer

Conditions

Breast Cancer, MetastaticBreast NeoplasmsCarcinoma, Non-Small-Cell Lung

Phase 2

Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients

CompletedNCT00044525

BayerBreast Cancer, Metastatic, Breast Neoplasms

Start: 2002-04-30End: 2004-02-29Updated: 2014-12-23

Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients

CompletedNCT00044538

BayerCarcinoma, Non-Small-Cell Lung

Start: 2001-12-31End: 2004-06-30Updated: 2009-06-22